The acne treatment market is expanding steadily due to ongoing demand among adolescents and adults worldwide. It includes a spectrum of solutions—from over-the-counter cleansers, creams, and topical treatments to prescription medications (like retinoids, antibiotics, and hormonal therapies), as well as in-office procedures such as chemical peels, laser therapy, and phototherapy. Key growth drivers include increasing skincare awareness, rising interest in aesthetic wellness, and innovations in formulations and delivery methods. With a shift toward personalized skincare routines and minimally invasive treatments, the acne treatment market continues evolving to meet consumer preferences and dermatological needs.
According to Fortune Business Insights, the global acne treatment market was valued at USD 11.62 billion in 2024. The market is projected to grow from USD 12.19 billion in 2025 to USD 17.48 billion by 2032, exhibiting a CAGR of 5.3% during the forecast period. In 2023, North America dominated the acne treatment market with a market share of 49.14%.
In October 2023, tbh Skincare entered an agreement with Coles (Australia) to launch its acne treatment products in 857 Coles stores nationwide—marking widespread retail accessibility and consumer convenience.